Clinical Trial Update: Erlotinib Plus Carboplatin and Paclitaxel in Ovarian Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating erlotinib in combination with carboplatin and paclitaxel in ovarian and related cancers. The study has completed and results were poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brenner Tumor
• Clear Cell Ovarian Cancer
• Endometrioid Ovarian Cancer
• Fallopian Tube Cancer
• Mucinous Ovarian Cancer
• Ovarian Epithelial Cancer
• Serous Ovarian Cancer
• Undifferentiated Ovarian Cancer

Drugs mentioned

• Paraplatin (Carboplatin)
• Tarceva (erlotinib)
• Taxol (paclitaxel)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Brenner Tumor, Fallopian Tube Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-12-01